A preclinical CRO built for the future
AmplifyBio partners with clients to provide preclinical CRO services, including toxicology, safety, efficacy, and characterization studies, and is further creating a novel development environment for the commercialization of both traditional small molecule drugs and advanced therapies. Spun out of Battelle in May of 2021, AmplifyBio continues to provide exceptional CRO study services in an agile environment better suited to commercial goals and with expanded bioanalytic capabilities.